Rapamycin
Brainstem Stroke
Huashan HospitalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Brainstem Stroke cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETONOGESTREL Shanghai StairMed Technology Co., Ltd. | N/A | D |
Same molecule, other indications
Rapamycin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →